
Category: pathogens
April 5, 2023 / Eur Heart J Cardiovasc Pharmacother
Vascular mechanisms of post-COVID-19 conditions: Rho-kinase is a novel target for therapy
Background: In post-coronavirus disease-19 (post-COVID-19) conditions (long COVID), systemic vascular dysfunction is implicated, but the mechanisms are uncertain, and the treatment is imprecise. Methods and results: Patients convalescing after hospitalization…
January 24, 2023 / JCI Insight
Spatial transcriptomic characterization of COVID-19 pneumonitis identifies immune circuits related to tissue injury
Severe lung damage resulting from COVID-19 involves complex interactions between diverse populations of immune and stromal cells. In this study, we used a spatial transcriptomics approach to delineate the cells,…
September 15, 2022 / Immunology
Transcriptomic profiling of cardiac tissues from SARS-CoV-2 patients identifies DNA damage
August 24, 2022 / Lancet Respir Med
Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study
July 11, 2022 / Am J Respir Crit Care Med
Prevalence and Mechanisms of Mucus Accumulation in COVID-19 Lung Disease
July 7, 2022 / Sci Transl Med
SARS-CoV-2 infection produces chronic pulmonary epithelial and immune cell dysfunction with fibrosis in mice
July 5, 2022 / Brain
Neurovascular injury with complement activation and inflammation in COVID-19
February 26, 2022 / Kidney Int
Digital spatial profiling of collapsing glomerulopathy
January 24, 2022 / Cell Rep Med